CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE. Global Conference on Medical and Health Sciences, [S. l.], v. 1, n. 9, p. 29–36, 2026. Disponível em: http://econferencia.com/index.php/5/article/view/1409. Acesso em: 15 sep. 2026.